Thu, August 25, 2022
Wed, August 24, 2022
Tue, August 23, 2022
Mon, August 22, 2022
Fri, August 19, 2022
Thu, August 18, 2022
Wed, August 17, 2022

Salveen Richter Maintained (BLUE) at Strong Sell with Increased Target to $3 on, Aug 19th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-increased-target-to-3-on-aug-19th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Salveen Richter of Goldman Sachs, Maintained "bluebird bio, Inc." (BLUE) at Strong Sell with Increased Target from $2 to $3 on, Aug 19th, 2022.

Salveen has made no other calls on BLUE in the last 4 months.



There are 4 other peers that have a rating on BLUE. Out of the 4 peers that are also analyzing BLUE, 2 agree with Salveen's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Mani Foroohar of "SVB Leerink" Maintained at Hold with Increased Target to $10 on, Thursday, August 18th, 2022
  • Gena Wang of "Barclays" Upgraded from Sell to Hold and Increased Target to $5 on, Friday, August 5th, 2022


These are the ratings of the 2 analyists that currently disagree with Salveen


  • Dane Leone of "Raymond James" Upgraded from Hold to Buy and Held Target at $8 on, Tuesday, August 2nd, 2022
  • Matthew Harrison of "Morgan Stanley" Maintained at Sell with Decreased Target to $3 on, Tuesday, May 17th, 2022

Publication Contributing Sources